[PDF][PDF] Revisiting amantadine as a treatment for drug-induced movement disorders
SN Caroff, R Jain, JF Morley - Ann Clin Psychiatry, 2020 - mhaus.org
BACKGROUND: Amantadine, an aliphatic primary amine with complex actions on
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …
Revisiting amantadine as a treatment for drug-induced movement disorders.
SN Caroff, R Jain, JF Morley - Annals of Clinical Psychiatry, 2020 - psycnet.apa.org
Background: Amantadine, an aliphatic primary amine with complex actions on
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …
Revisiting amantadine as a treatment for drug-induced movement disorders
SN Caroff, R Jain, JF Morley - Annals of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Amantadine, an aliphatic primary amine with complex actions on
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …
Revisiting amantadine as a treatment for drug-induced movement disorders.
SN Caroff, R Jain, JF Morley - … Journal of the American Academy of …, 2020 - europepmc.org
Background Amantadine, an aliphatic primary amine with complex actions on
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …